Abomin Tablets 50000 IU (Tablets) Instructions for Use
Marketing Authorization Holder
Novosibirsk Medical Preparations Plant JSC (Russia)
ATC Code
A09AA (Enzyme preparations)
Dosage Form
| Abomin Tablets 50000 IU | Tablets 50 thousand IU: 10 pcs. |
Dosage Form, Packaging, and Composition
Tablets from light yellow to yellowish-gray in color, biconvex, with a faint specific odor characteristic of rennet; inclusions of varying intensity, unevenly distributed on the tablet surface, are allowed.
| 1 tab. | |
| Rennet enzymes of milk-fed calves and lambs (containing lactose*) | 50 thousand IU |
* lactose content not less than 70%.
Excipients: potato starch, calcium stearate.
10 pcs. – non-blister contour packs.
10 pcs. – blister contour packs.
10 pcs. – blister contour packs (3) – cardboard cartons.
Clinical-Pharmacological Group
Enzyme preparation
Pharmacotherapeutic Group
Digestive enzyme agent
Pharmacological Action
Proteolytic enzyme, acts on food (primarily milk) proteins.
Indications
Diseases of the gastrointestinal tract accompanied by impaired digestive capacity and decreased acidity of gastric juice ( gastritis, gastroenteritis, enterocolitis).
ICD codes
| ICD-10 code | Indication |
| K29 | Gastritis and duodenitis |
| K52 | Other noninfectious gastroenteritis and colitis |
| ICD-11 code | Indication |
| DA42.81 | Radiation gastritis |
| DA42.8Z | Gastritis due to external causes, unspecified |
| DA42.Z | Gastritis, unspecified |
| DA51.53 | Radiation duodenitis |
| DA51.5Z | Duodenitis due to external causes, unspecified |
| DA51.Z | Duodenitis, unspecified |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DB33.2Z | Allergic or alimentary colitis, unspecified |
| DB33.4Y | Other specified colitis or proctitis caused by external agents |
| DB33.4Z | Colitis or proctitis caused by external agents, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Orally, during meals, 1 tab. (50 thousand IU) 3 times/day. The treatment course is 1-2 months.
If the effect is insufficient – 3 tabs. per dose, the course is extended to 3 months.
For acute gastritis, gastroenteritis, and colitis – 1 tab. 3 times/day for 2-3 days.
For children under one year of age – 1/2 of a children’s tab. (10 thousand IU), 2-5 years – 1 tab., 6-9 years – 2 tabs., 10-14 years – 3 tabs. The treatment course is 1-3 months.
Adverse Reactions
Possiblenausea, heartburn.
Contraindications
Hypersensitivity; vomiting and regurgitation syndrome in young children.
Pediatric Use
Children under one year of age – 1/2 of a children’s tab. (10 thousand IU), 2-5 years – 1 tab., 6-9 years – 2 tabs., 10-14 years – 3 tabs. The treatment course is 1-3 months.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer